Evidence map›Paper›PMID 35779513›Full record

ArticleBioorganic & medicinal chemistry2022

MicroRNA detection in biologically relevant media using a split aptamer platform.

Liming Wang, Kern Hast, Tushar Aggarwal, Melih Baci, Jonathan Hong, Enver Cagri Izgu

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liming WangDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA.
Kern HastDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA.
Tushar AggarwalDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA.
Melih BaciDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA.
Jonathan HongDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA.
Enver Cagri IzguDepartment of Chemistry and Chemical Biology, Rutgers University, New Brunswick, NJ 08854, USA; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08901, USA; Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, NJ 08901, USA.
Rutgers, The State University of New Jersey · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Activity-Based Aptamers as Bioimaging Tools for Probing Organics, Inorganics, and EnzymesR21EB029548 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI IZGU, ENVER C · 2020 to 2021
$615k
NCI NIH HHS P30 CA072720NIBIB NIH HHS R21 EB029548
6 · The paper itself

Abstract

MicroRNA (miRNA)-based intercellular communication has been implicated in many functional and dysfunctional biological processes. This has raised interest in the potential use of miRNAs as biomarkers for diagnosis and prognosis. Though the list of clinically significant miRNA biomarkers is expanding, it remains challenging to adapt current chemical tools to investigate miRNAs in complex environments native to cells and tissues. We describe here a methodology for rapidly developing aptamer-based fluorescent biosensors that can specifically detect miRNAs in biologically relevant media (10-30% v/v), including medium collected from cultured HeLa cells, human serum, and human plasma. This methodology involves the semi-rational design of the hybridization between DNA oligonucleotides and the miRNA target to build a pool of potential aptamers, and the screening of this pool for high signal-to-background ratio and target specificity. The DNA oligonucleotides are readily available and require no chemical modification, rendering these chemical tools highly adaptable to any novel and niche miRNA target. Following this approach, we developed sensors that detect distinct oncogenic miRNA targets (miR-19b, miR-21, and miR-92a) at concentrations as low as 5 nM without amplification and are selective against single-nucleotide mutants. This work provides a systematic approach toward the development of miRNA biosensors that are easily accessible and can perform in biological environments with minimal sample handling.

Indexed as

Aptamers, NucleotideMicroRNAsBiomarkersDNAHeLa CellsHumansAptamers, NucleotideBiomarkersDNAMicroRNAsAptamerFluorescent detectionMiRNANucleic acidSmall-molecule fluorophore

Identifiers

PMID35779513
PMCPMC9339231
OpenAlexW4283719365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.